Literature DB >> 12413084

Brewers dried yeast as a source of mannan oligosaccharides for weanling pigs.

L A White1, M C Newman, G L Cromwell, M D Lindemann.   

Abstract

Brewers dried yeast, a source of mannan oligosaccharides (MOS), was assessed as an alternative to an antimicrobial agent (carbadox) for young pigs in two experiments. The yeast contained 5.2% MOS. Agglutination tests confirmed adsorption of several serovars of E. coli and Salmonella spp. onto the yeast product. In Exp. 1, seven replicates (five pigs per pen) of 22-d-old pigs were fed a nonmedicated basal diet or the basal diet with carbadox (55 mg/kg), yeast (3%), or a combination of 3% yeast and 2% citric acid for 28 d. Carbadox did not improve growth performance. Growth rate and feed intake were depressed (P < 0.05) in pigs fed yeast alone or in combination with acid. Log counts of total coliforms, Escherichia coli, and Clostridium perfringens in feces were not affected by diet, but Bifidobacteria spp. counts were lower (P < 0.05) in pigs fed the yeast + acid diet and lactobacilli counts were higher (P < 0.05) in pigs fed yeast. Fecal pH and VFA concentrations and intestinal morphological traits were not consistently affected by diet. Serum IgG levels were elevated in the yeast + acid (P < 0.01) group. In Exp. 2, the effects of yeast and carbadox additions to the diet on enteric microbial populations in young pigs housed in isolation units were evaluated. Pigs (n = 24) were weaned at 11 d of age (4.1 kg BW) and placed in isolation chambers (two pigs per chamber) equipped with individual air filtering systems and excrement containers. Treatments were a nonmedicated basal diet and the basal diet with 55 mg/kg of carbadox or with 3% yeast. Diets were fed for 29 d, then each pig was orally dosed with approximately 9.5 x 10(8) CFU of E. coli K88. Daily fecal E. coli K88 counts were not different (P > 0.05) among treatments, but fecal shedding of carbadox-resistant coliforms was higher (P < 0.01) during the 9-d period in pigs fed carbadox. Total fecal coliforms were consistently lower throughout the postinoculation period in pigs fed yeast (P < 0.05). Yeast reduced colonization oftotal coliforms in the duodenum,jejunum, cecum, and colon, but it did not have a consistent effect on colonization of E. coli K88. Pigs fed yeast tended (P < 0.10) to have higher serum IgG levels than controls. In these experiments, brewers dried yeast and carbadox had minimal effects on growth, microbial populations, and intestinal health traits of early-weaned pigs, but certain serum immunological traits were enhanced by feeding yeast.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12413084     DOI: 10.2527/2002.80102619x

Source DB:  PubMed          Journal:  J Anim Sci        ISSN: 0021-8812            Impact factor:   3.159


  30 in total

1.  β-Galactomannan and Saccharomyces cerevisiae var. boulardii modulate the immune response against Salmonella enterica serovar Typhimurium in porcine intestinal epithelial and dendritic cells.

Authors:  Roger Badia; M Teresa Brufau; Ana Maria Guerrero-Zamora; Rosil Lizardo; Irina Dobrescu; Raquel Martin-Venegas; Ruth Ferrer; Henri Salmon; Paz Martínez; Joaquim Brufau
Journal:  Clin Vaccine Immunol       Date:  2012-02-01

2.  Effect of yeast polysaccharide on some hematologic parameter and gut morphology in channel catfish (Ictalurus punctatus).

Authors:  Huiling Zhu; Huiyu Liu; Jing Yan; Rui Wang; Lihe Liu
Journal:  Fish Physiol Biochem       Date:  2012-03-22       Impact factor: 2.794

Review 3.  The prebiotic potential of brewers' spent grain on livestock's health: a review.

Authors:  Emanuel Joel Lao; Noel Dimoso; Jofrey Raymond; Ernest Rashid Mbega
Journal:  Trop Anim Health Prod       Date:  2020-01-03       Impact factor: 1.559

4.  Influence of dietary supplementation of prebiotics (mannanoligosaccharide) on the performance of crossbred calves.

Authors:  Sudipta Ghosh; Ram Kumar Mehla
Journal:  Trop Anim Health Prod       Date:  2011-07-31       Impact factor: 1.559

5.  The Nutritional Value and Physiological Properties of Diets with Raw and Candida utilis-Fermented Lupin Seeds in Rats.

Authors:  Małgorzata Kasprowicz-Potocka; Anita Zaworska; Andrzej Frankiewicz; Włodzimierz Nowak; Piotr Gulewicz; Zenon Zduńczyk; Jerzy Juśkiewicz
Journal:  Food Technol Biotechnol       Date:  2015-09       Impact factor: 3.918

6.  Immunomodulatory effects of whole yeast cells and capsicum in weanling pigs challenged with pathogenic Escherichia coli1.

Authors:  Samantha J Wojnicki; Antrison Morris; Brooke Nicole Smith; Carol W Maddox; Ryan Neil Dilger
Journal:  J Anim Sci       Date:  2019-04-03       Impact factor: 3.159

7.  Effects of Saccharomyces cerevisiae var. boulardii CNCM I-1079 on performance, colostrum and milk composition, and litter performance of mixed-parity sows in a tropical humid climate.

Authors:  Victória Pontes Rocha; Lina Raquel Santos Araújo; Ingrid Barbosa de Mendonça; Lucas Paz Martins; Gabriel Gobira de Alcântara Araújo; Pedro Henrique Watanabe; Tiago Silva Andrade; José Nailton Bezerra Evangelista
Journal:  Trop Anim Health Prod       Date:  2022-01-10       Impact factor: 1.559

Review 8.  Application of anhydrobiosis and dehydration of yeasts for non-conventional biotechnological goals.

Authors:  Alexander Rapoport; Benedetta Turchetti; Pietro Buzzini
Journal:  World J Microbiol Biotechnol       Date:  2016-04-27       Impact factor: 3.312

9.  Effects of mannan oligosaccharides and Lactobacillus mucosae on growth performance, immune response, and gut health of weanling pigs challenged with Escherichia coli lipopolysaccharides.

Authors:  Yanshuo S Li; Joice V San Andres; Melanie D Trenhaile-Grannemann; Dana M van Sambeek; Kelly C Moore; Shana M Winkel; Samodha C Fernando; Thomas E Burkey; Phillip S Miller
Journal:  J Anim Sci       Date:  2021-12-01       Impact factor: 3.159

10.  Modulation of the growth performance and innate immunity of loaches (Paramisgurnus dabryanus) upon dietary mannan oligosaccharides.

Authors:  Bing Xu; Shengjun Wu; Qi Han
Journal:  3 Biotech       Date:  2021-02-20       Impact factor: 2.406

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.